Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
about
Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3.Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis.Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Viral hepatitis and liver cancer.Hepatic stellate cells as key target in liver fibrosis.Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Implementing genetic screening for the management of hepatic disease.Combination of Gene Expression Signature and Model for End-stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.Genome-Wide Expression Profiles Drive Discovery of Novel Compounds that Reduce Binge Drinking in Mice.Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer.Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis.Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities.A Simple Diet- and Chemical-Induced Murine NASH Model with Rapid Progression of Steatohepatitis, Fibrosis and Liver Cancer.Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.Identification of The Aberrantly Expressed LncRNAs in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on RNA-sequencing.Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes.Oncogenic Signaling Induced by HCV Infection
P2860
Q30253010-539501D9-ADF9-45FB-942B-2D9C99DC59DCQ33920344-3AFBD50E-3975-41A9-8B5B-4BA5C57AD23AQ36306768-64C18BE9-5574-43E2-AE10-AAD0CE93AC2CQ39197775-56F9B47F-DEF3-4806-A937-CE7C55EAB701Q40046596-AC9F793A-9EF5-43A4-BFD5-C1996305DBB6Q40200602-1C943089-DD9C-4431-B67D-ACBC27EC9F7AQ40252283-9CF27FEB-B968-4E30-AD5E-D61212DB534FQ41670848-43ADFB3C-1135-4C11-92CE-1E1E99BD49DBQ41921861-5DCA3E90-FA95-4427-ADDD-F536E66F1F18Q47145796-6C1B52B8-AE5A-4513-B5BE-0810D641E946Q47439747-7DD91D69-AAE3-4514-AA5C-65DED6D0B9F2Q47621546-4D2463BF-7DD3-4389-A28A-82435CBB25D5Q47910117-701DC12D-814E-41DE-8DC6-4FF297EB05A4Q48595289-CC9F3711-524B-4CE0-9528-D2B3E9B7ECD7Q48762101-1C698262-B426-4198-9D7D-42EBC6FFB78AQ49959228-B0727DE7-957D-47BE-8AFF-8A4D37F61548Q50074055-3D1F9523-1A37-413B-828C-B1706AD8120BQ50087420-BFA015A4-77CF-40BF-ACBB-2CA79E3B6419Q52639618-31B25596-5FD8-4116-8923-599136F2406CQ52689639-D54E5973-879D-4C00-BF16-A7266B1E8A37Q52723073-94D3D11D-B0C2-4582-A557-25312FE9693CQ54242128-63BD25EE-0D3B-40CB-9980-DED08921631EQ55442577-A2D91EE5-3A92-4D0E-99AE-7481897DA04CQ57050806-76F836A4-E42D-434B-B616-0ABF3D766FA1
P2860
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Molecular Liver Cancer Prevent ...... tidic Acid Pathway Inhibition.
@en
type
label
Molecular Liver Cancer Prevent ...... tidic Acid Pathway Inhibition.
@en
prefLabel
Molecular Liver Cancer Prevent ...... tidic Acid Pathway Inhibition.
@en
P2093
P2860
P50
P1433
P1476
Molecular Liver Cancer Prevent ...... tidic Acid Pathway Inhibition.
@en
P2093
Andrew M Tager
Anna P Koh
Anu Venkatesh
Aravind Subramanian
C Billie Bian
Chia-Yen Dai
Derek J Erstad
Ganesh Gunasekaran
Gregory Y Lauwers
P2860
P304
P356
10.1016/J.CCELL.2016.11.004
P577
2016-12-01T00:00:00Z